Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Conservative Prescribing and the Importance of Psychotherapy—Reply

Conservative Prescribing and the Importance of Psychotherapy—Reply In reply It is unlikely that direct-to-consumer ads are going to be banned any time soon. This underscores the need to provide physicians and patients with independent, balanced information about the benefits, harms, and uncertainties of Food and Drug Administration (FDA)-approved prescription drugs. A number of groups have undertaken such efforts including academics,1 policy groups,2 and consumer organizations.3 We have proposed that the FDA itself produce standardized 1-page summaries, called drug facts boxes, to provide the necessary information. On the basis of a body of evidence, including national randomized trials demonstrating that drug boxes improve patient decision making,4 the FDA's Risk Communication Advisory Committee unanimously recommended that the FDA adopt the Drug Facts Box as the standard format for all communications. Unfortunately, the FDA has made no steps toward implementing this recommendation.5 The rapid uptake of many newly approved drugs—often with minimal benefits over placebo and uncertain safety records—suggests physicians may also overinterpret the meaning of FDA approval in terms of drug efficacy and safety. Physicians clearly need better drug information also. Back to top Article Information Correspondence: Dr Woloshin, The Dartmouth Institute for Health Policy and Clinical Practice, VA Medical Center, 215 N Main St, White River Junction, VT 05009 (steven.woloshin@dartmouth.edu). Financial Disclosure: None reported. References 1. Avorn J. Teaching clinicians about drugs—50 years later, whose job is it? N Engl J Med. 2011;364(13):1185-118721449781PubMedGoogle ScholarCrossref 2. Center for Evidence-based Policy and the Oregon Evidence-based Practice Center. Drug Effectiveness Review Project (DERP). Oregon Health & Science University. http://www.ohsu.edu/xd/research/centers-institutes/evidence-based-policy-center/derp/index.cfm/. Accessed November 1, 2011 3. Consumer Reports. Best buy drugs. http://www.consumerreports.org/health/prescription-drugs/index.htm. Accessed November 1, 2011 4. Schwartz LM, Woloshin S, Welch HG. Using a drug facts box to communicate drug benefits and harms: two randomized trials. Ann Intern Med. 2009;150(8):516-52719221371PubMedGoogle Scholar 5. Woloshin S, Schwartz L. Think inside the box. New York Times. July 5, 2011:A21 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Internal Medicine American Medical Association

Conservative Prescribing and the Importance of Psychotherapy—Reply

Loading next page...
 
/lp/american-medical-association/conservative-prescribing-and-the-importance-of-psychotherapy-reply-T7ZfYIXQGi
Publisher
American Medical Association
Copyright
Copyright © 2012 American Medical Association. All Rights Reserved.
ISSN
0003-9926
eISSN
1538-3679
DOI
10.1001/archinternmed.2011.1405
Publisher site
See Article on Publisher Site

Abstract

In reply It is unlikely that direct-to-consumer ads are going to be banned any time soon. This underscores the need to provide physicians and patients with independent, balanced information about the benefits, harms, and uncertainties of Food and Drug Administration (FDA)-approved prescription drugs. A number of groups have undertaken such efforts including academics,1 policy groups,2 and consumer organizations.3 We have proposed that the FDA itself produce standardized 1-page summaries, called drug facts boxes, to provide the necessary information. On the basis of a body of evidence, including national randomized trials demonstrating that drug boxes improve patient decision making,4 the FDA's Risk Communication Advisory Committee unanimously recommended that the FDA adopt the Drug Facts Box as the standard format for all communications. Unfortunately, the FDA has made no steps toward implementing this recommendation.5 The rapid uptake of many newly approved drugs—often with minimal benefits over placebo and uncertain safety records—suggests physicians may also overinterpret the meaning of FDA approval in terms of drug efficacy and safety. Physicians clearly need better drug information also. Back to top Article Information Correspondence: Dr Woloshin, The Dartmouth Institute for Health Policy and Clinical Practice, VA Medical Center, 215 N Main St, White River Junction, VT 05009 (steven.woloshin@dartmouth.edu). Financial Disclosure: None reported. References 1. Avorn J. Teaching clinicians about drugs—50 years later, whose job is it? N Engl J Med. 2011;364(13):1185-118721449781PubMedGoogle ScholarCrossref 2. Center for Evidence-based Policy and the Oregon Evidence-based Practice Center. Drug Effectiveness Review Project (DERP). Oregon Health & Science University. http://www.ohsu.edu/xd/research/centers-institutes/evidence-based-policy-center/derp/index.cfm/. Accessed November 1, 2011 3. Consumer Reports. Best buy drugs. http://www.consumerreports.org/health/prescription-drugs/index.htm. Accessed November 1, 2011 4. Schwartz LM, Woloshin S, Welch HG. Using a drug facts box to communicate drug benefits and harms: two randomized trials. Ann Intern Med. 2009;150(8):516-52719221371PubMedGoogle Scholar 5. Woloshin S, Schwartz L. Think inside the box. New York Times. July 5, 2011:A21

Journal

Archives of Internal MedicineAmerican Medical Association

Published: Feb 13, 2012

Keywords: psychotherapy,prescribing behavior

References